Aardvark Therapeutics Shares Crater: FDA Halts Promising Prader-Willi Syndrome Drug
Aardvark Therapeutics Shares Plummet as FDA Halts Crucial Prader-Willi Drug Trial
Another Heartbreaking Setback in the Pursuit of Prader-Willi Syndrome Treatments